Ryota Iwase

668 total citations
38 papers, 544 citations indexed

About

Ryota Iwase is a scholar working on Oncology, Surgery and Cancer Research. According to data from OpenAlex, Ryota Iwase has authored 38 papers receiving a total of 544 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Oncology, 18 papers in Surgery and 9 papers in Cancer Research. Recurrent topics in Ryota Iwase's work include Pancreatic and Hepatic Oncology Research (16 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (9 papers) and Inflammatory Biomarkers in Disease Prognosis (9 papers). Ryota Iwase is often cited by papers focused on Pancreatic and Hepatic Oncology Research (16 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (9 papers) and Inflammatory Biomarkers in Disease Prognosis (9 papers). Ryota Iwase collaborates with scholars based in Japan. Ryota Iwase's co-authors include Katsuhiko Yanaga, Koichiro Haruki, Kenei Furukawa, Hiroaki Shiba, Yuki Fujiwara, Takeyuki Misawa, Yoshihiro Shirai, Takashi Horiuchi, Yasuro Futagawa and Tadashi Uwagawa and has published in prestigious journals such as SHILAP Revista de lepidopterología, Cancer Letters and Journal of the American College of Surgeons.

In The Last Decade

Ryota Iwase

35 papers receiving 537 citations

Peers

Ryota Iwase
Ryota Iwase
Citations per year, relative to Ryota Iwase Ryota Iwase (= 1×) peers Seyed Reza Fatemi

Countries citing papers authored by Ryota Iwase

Since Specialization
Citations

This map shows the geographic impact of Ryota Iwase's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ryota Iwase with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ryota Iwase more than expected).

Fields of papers citing papers by Ryota Iwase

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ryota Iwase. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ryota Iwase. The network helps show where Ryota Iwase may publish in the future.

Co-authorship network of co-authors of Ryota Iwase

This figure shows the co-authorship network connecting the top 25 collaborators of Ryota Iwase. A scholar is included among the top collaborators of Ryota Iwase based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ryota Iwase. Ryota Iwase is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sekine, Keisuke, Keigo Nakashima, Teppei Kamada, et al.. (2024). Solitary fibrous tumor of the gallbladder: a case report. Surgical Case Reports. 10(1). 263–263. 1 indexed citations
2.
Taniai, Tomohiko, Kenei Furukawa, Yoshihiro Shirai, et al.. (2023). Dynamics of the prognostic nutritional index in preoperative chemotherapy in patients with colorectal liver metastases. Surgical Oncology. 49. 101966–101966. 3 indexed citations
3.
Aida, Takashi, Ryota Iwase, Kenei Furukawa, et al.. (2023). Successful resection of port site recurrence of pancreatic ductal adenocarcinoma after laparoscopic distal pancreatectomy. SHILAP Revista de lepidopterología. 9(1). 35–35. 1 indexed citations
4.
Sakamoto, Taro, Masashi Tsunematsu, Yoshihiro Shirai, et al.. (2022). D1 Distal Pancreatectomy for Left-sided Pancreatic Ductal Adenocarcinoma Is Justifiable: A Propensity-score Matched Multicenter Study. Anticancer Research. 43(1). 201–208. 1 indexed citations
5.
Hamura, Ryoga, Koichiro Haruki, Ryota Iwase, et al.. (2021). Ischemic small bowel perforation caused by cholesterol crystal embolism following transcatheter arterial chemoembolization for recurrent hepatocellular carcinoma: a case report. SHILAP Revista de lepidopterología. 7(1). 45–45. 2 indexed citations
6.
Furukawa, Kenei, Ryota Iwase, Jungo Yasuda, et al.. (2019). Risk Factors for Deterioration of Remnant Liver Function After Hepatic Resection for Hepatocellular Carcinoma. Anticancer Research. 39(10). 5755–5760. 5 indexed citations
7.
Horiuchi, Takashi, Koichiro Haruki, Hiroaki Shiba, et al.. (2019). Assessment of Outcome of Hepatic Resection for Extremely Elderly Patients With a Hepatic Malignancy. Anticancer Research. 39(11). 6325–6332. 6 indexed citations
8.
Iwase, Ryota, Yutaka Suzuki, Eigoro Yamanouchi, et al.. (2018). Double Percutaneous Transesophageal Gastrotubing for Gastric Cancer: A Pilot Study. Journal of Surgical Research. 232. 470–474. 8 indexed citations
9.
Furukawa, Kenei, Takeshi Gocho, Yoshihiro Shirai, et al.. (2016). The Decline of Amylase Level of Pancreatic Juice After Pancreaticoduodenectomy Predicts Postoperative Pancreatic Fistula. Pancreas. 45(10). 1474–1477. 9 indexed citations
10.
Horiuchi, Takashi, Tadashi Uwagawa, Yoshihiro Shirai, et al.. (2016). New treatment strategy with nuclear factor-κB inhibitor for pancreatic cancer. Journal of Surgical Research. 206(1). 1–8. 8 indexed citations
11.
Haruki, Koichiro, Hiroaki Shiba, Takashi Horiuchi, et al.. (2016). Neutrophil to Lymphocyte Ratio Predicts Therapeutic Outcome After Pancreaticoduodenectomy for Carcinoma of the Ampulla of Vater.. PubMed. 36(1). 403–8. 19 indexed citations
12.
Shirai, Yoshihiro, Hiroaki Shiba, Ryota Iwase, et al.. (2015). Dual inhibition of nuclear factor kappa-B and Mdm2 enhance the antitumor effect of radiation therapy for pancreatic cancer. Cancer Letters. 370(2). 177–184. 18 indexed citations
13.
Fujiwara, Yuki, Hiroaki Shiba, Yoshihiro Shirai, et al.. (2015). Perioperative serum albumin correlates with postoperative pancreatic fistula after pancreaticoduodenectomy.. PubMed. 35(1). 499–503. 26 indexed citations
14.
Furukawa, Kenei, Hiroaki Shiba, Yoshihiro Shirai, et al.. (2015). Negative Impact of Preoperative Endoscopic Biliary Drainage on Prognosis of Pancreatic Ductal Adenocarcinoma After Pancreaticoduodenectomy.. PubMed. 35(9). 5079–83. 15 indexed citations
15.
Shiba, Hiroaki, Takeyuki Misawa, Yuki Fujiwara, et al.. (2014). Glasgow Prognostic Score Predicts Outcome After Surgical Resection of Gallbladder Cancer. World Journal of Surgery. 39(3). 753–758. 33 indexed citations
16.
Iwase, Ryota, Koichiro Haruki, Yuki Fujiwara, et al.. (2013). Combination chemotherapy of nafamostat mesylate with gemcitabine for gallbladder cancer targeting nuclear factor-κB activation. Journal of Surgical Research. 184(1). 605–612. 19 indexed citations
17.
Gocho, Takeshi, Tadashi Uwagawa, Kenei Furukawa, et al.. (2013). Combination chemotherapy of serine protease inhibitor nafamostat mesilate with oxaliplatin targeting NF-κB activation for pancreatic cancer. Cancer Letters. 333(1). 89–95. 26 indexed citations
18.
Fujiwara, Yuki, Hiroaki Shiba, Ryota Iwase, et al.. (2012). Inhibition of Nuclear Factor Kappa-B Enhances the Antitumor Effect of Combination Treatment with Tumor Necrosis Factor-Alpha Gene Therapy and Gemcitabine for Pancreatic Cancer in Mice. Journal of the American College of Surgeons. 216(2). 320–332e3. 16 indexed citations
19.
Furukawa, Kenei, Tadashi Uwagawa, Ryota Iwase, et al.. (2012). Prognostic factors of unresectable pancreatic cancer treated with nafamostat mesilate combined with gemcitabine chemotherapy.. PubMed. 32(11). 5121–6. 8 indexed citations
20.
Haruki, Koichiro, Hiroaki Shiba, Yuki Fujiwara, et al.. (2012). Inhibition of Nuclear Factor-κB Enhances the Antitumor Effect of Paclitaxel Against Gastric Cancer with Peritoneal Dissemination in Mice. Digestive Diseases and Sciences. 58(1). 123–131. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026